General Information

Signum Preemptive Healthcare Inc.

	Address	223 Avenue Saint-Charles Vaudreuil-Dorion, J7V 2L6 Canada
	Address type	Registered Office Address
	Address province	Quebec

	Corporation ID	8950342
	Business number	843208182
	Status	Active
	ACT	Canada Business Corporations Act
	Anniversary date	07/10/2014
	Last annual filing	2026
	Data verified	10/31/2026

Description

Signum Preemptive Healthcare Inc. is an active enterprise which was registered under Canada Business Corporations Act with a corporation no 8950342 (business number 843208182). The incorporation was done on 2014-07-10. The company is located in Vaudreuil-Dorion at 223 Avenue Saint-Charles, J7V 2L6 in Quebec administrative division. To our knowledge, the latest yearly meeting was on 2015-12-11.
Additional companies in the vicinity are: Viking Xperts Inc., 6871721 Canada Inc., Canadian Information Technology Solutions Inc., 8198152 Canada Inc., Atri.buts Consultants Inc..

Approximate location (postal code area): GeoNames (CC BY 4.0).

Company names

Name	Effective date	Type	Current
8950342 Canada Inc.	07/10/2014	Corporate Name
Signum Preemptive Healthcare Inc.	12/16/2014	Corporate Name	true

Directors

Jean-Pierre Desmarais
,

Deepak Bobby Jain
,

Robert Hecht
,

last updated: 2026-10-30

Government Grants and Contributions

3 federal grants and contributions in 2020 with a total value of $180,055.

Start date	Department and program	Value
12/20/2020	National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2.5 The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.	$32,515
06/25/2020	National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2 The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small and medium-sized enterprises that are unable to access existing COVID-19 business support.	$86,556
04/01/2020	National Research Council Canada Innovation Assistance Program (contribution) The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.	$60,984

Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.

Company activities

Date	Type	Section
12/16/2014	Amendment	6
07/10/2014	Incorporation

Company annual return

Meeting date	Type of corporation	Year of filing
12/11/2015	Non-distributing corporation with 50 or fewer shareholders	2017